The two pharmaceutical companies Regeneron Pharmaceuticals and Sanofi reported that the cholesterol reducing drug alirocumab has successfully passed the two new ODYSSEY trials. This is the first out of a 3 stage evaluation. The two trials evaluated the efficacy of a treatment based on alirocumab that was administered every four weeks. The tests compared the reduction from baseline in … [Read more...]
You are here: Home / Archives for Regeneron Pharmaceuticals and Sanofi reported alirocumab successfully passed two new ODYSSEY trials